William Powderly, Director, Institute for Public Health; J. William Campbell Professor of Medicine and Co-Director of the Division of Infectious Diseases, School of Medicine poses for a portrait at his office on Thursday, Sept. 11, 2014 in St. Louis. (Photo © Whitney Curtis)

William Powderly, M.D.

Dr. J. William Campbell Professor of Medicine and the Larry J. Shapiro Director of the Institute for Public Health at Washington University in St. Louis

Professor William Powderly, M.D., is the Dr. J. William Campbell Professor of Medicine and the Larry J. Shapiro Director of the Institute for Public Health at Washington University in St. Louis. He is also the director of the Institute for Clinical and Translational Sciences (ICTS) and co-director of the Division of Infectious Diseases at the Washington University School of Medicine. From 2005 to 2012, he was Dean of Medicine and Head of the School of Medicine at University College Dublin in Ireland. Dr. Powderly has been actively involved in HIV-related clinical research for thirty years. He has been a member of numerous advisory groups on HIV and infectious diseases for the National Institutes of Health (NIH), the U.S. Centers for Disease Control and Prevention, the Canadian Institute for Health Research, and the European Medicines Agency. He is currently a member of the NIH’s Office of AIDS Research Advisory Council. He also was the first chairman of the HIV Medicine Association. He is the author of over 400 original manuscripts, reviews and book chapters. His recent focus as Director of the Institute for Public Health has been on translating scientific advances to a wider population to improve public health. The Institute under his direction has focused on Implementation Science, Community Partnerships, Economic and Policy Research, and Global Health to broaden the impact of discovery science and address disparities in health outcomes. He is a Fellow of the Royal College of Physicians In Ireland, the Royal College of Physicians (London) and the American Association for the Advancement of Science, and was, in 2017, President of the Infectious Diseases Society of America.